Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Medtronic
Johnson and Johnson
Merck
Dow

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,071,977

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,071,977 protect, and when does it expire?

Patent 10,071,977 protects HETLIOZ and is included in one NDA.

This patent has four patent family members in three countries.

Summary for Patent: 10,071,977
Title:Highly purifid pharmaceutical grade tasimelteon
Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
Inventor(s): Phadke; Deepak (Olathe, KS), Platt; Natalie M (Columbia, MD), Pandrapragada; Ravi K (Clarksburg, MD)
Assignee: VANDA PHARMACEUTICALS INC. (Washington, DC)
Application Number:15/117,734
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,071,977
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Process;

Drugs Protected by US Patent 10,071,977

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vanda Pharms Inc HETLIOZ tasimelteon CAPSULE;ORAL 205677-001 Jan 31, 2014 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,071,977

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3105212   Start Trial
European Patent Office 3470405   Start Trial
Japan 2017506642   Start Trial
World Intellectual Property Organization (WIPO) 2015123389   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Merck
Moodys
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.